COPD Assessment Test and risk of readmission in patients with bronchiectasis: a prospective cohort study.

IF 4.3 3区医学 Q1 RESPIRATORY SYSTEM

ERJ Open Research Pub Date : 2024-03-18 eCollection Date: 2024-03-01 DOI:10.1183/23120541.00867-2023

Juan Wang, Xiaoting Chen, Siqi He, Jing Li, Tianyuan Ma, Lu Liu, Lei Zhang, Xiaoning Bu

{"title":"COPD Assessment Test and risk of readmission in patients with bronchiectasis: a prospective cohort study.","authors":"Juan Wang, Xiaoting Chen, Siqi He, Jing Li, Tianyuan Ma, Lu Liu, Lei Zhang, Xiaoning Bu","doi":"10.1183/23120541.00867-2023","DOIUrl":null,"url":null,"abstract":"Introduction: Readmission following bronchiectasis exacerbation is a common and challenging clinical problem and few simple predictive tools exist. The COPD Assessment Test (CAT) is an easy-to-use questionnaire. This study aims to evaluate the predictive value of CAT scores in determining the risk of readmission in patients with bronchiectasis exacerbation.Methods: We conducted a prospective cohort study in 106 bronchiectasis patients admitted with exacerbation. All patients completed the CAT at admission and at discharge. Patients were followed-up for 12 months to collect data on readmission. The area under the curve was used to measure the predictive value of CAT at admission, CAT at discharge and change in CAT for readmission due to bronchiectasis exacerbation.Results: 46 patients were readmitted for bronchiectasis exacerbation within 12 months. High CAT at admission was an independent risk factor for readmission within 12 months in patients with acute exacerbation of bronchiectasis (hazard ratio 3.201, 95% CI 1.065-9.624; p<0.038) after adjustment for confounding variables. The cut-off value of CAT at admission and CAT at discharge to predict 12-month readmission in patients with acute exacerbation of bronchiectasis was 23.5 (sensitivity 62.2%, specificity 83.6%) and 15.5 (sensitivity 52.2%, specificity 87.0%).Conclusions: CAT at admission is a strong predictor of readmission in patients with bronchiectasis exacerbation.","PeriodicalId":11739,"journal":{"name":"ERJ Open Research","volume":"10 2","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10945388/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ERJ Open Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/23120541.00867-2023","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Readmission following bronchiectasis exacerbation is a common and challenging clinical problem and few simple predictive tools exist. The COPD Assessment Test (CAT) is an easy-to-use questionnaire. This study aims to evaluate the predictive value of CAT scores in determining the risk of readmission in patients with bronchiectasis exacerbation.

Methods: We conducted a prospective cohort study in 106 bronchiectasis patients admitted with exacerbation. All patients completed the CAT at admission and at discharge. Patients were followed-up for 12 months to collect data on readmission. The area under the curve was used to measure the predictive value of CAT at admission, CAT at discharge and change in CAT for readmission due to bronchiectasis exacerbation.

Results: 46 patients were readmitted for bronchiectasis exacerbation within 12 months. High CAT at admission was an independent risk factor for readmission within 12 months in patients with acute exacerbation of bronchiectasis (hazard ratio 3.201, 95% CI 1.065-9.624; p<0.038) after adjustment for confounding variables. The cut-off value of CAT at admission and CAT at discharge to predict 12-month readmission in patients with acute exacerbation of bronchiectasis was 23.5 (sensitivity 62.2%, specificity 83.6%) and 15.5 (sensitivity 52.2%, specificity 87.0%).

Conclusions: CAT at admission is a strong predictor of readmission in patients with bronchiectasis exacerbation.

查看原文本刊更多论文

慢性阻塞性肺病评估测试与支气管扩张患者再入院风险：一项前瞻性队列研究。

简介支气管扩张加重后再入院是一个常见且具有挑战性的临床问题，但目前几乎没有简单的预测工具。慢性阻塞性肺病评估测试（COPD Assessment Test，CAT）是一种易于使用的问卷。本研究旨在评估 CAT 评分在确定支气管扩张患者再入院风险方面的预测价值：我们对 106 名因病情加重而入院的支气管扩张症患者进行了前瞻性队列研究。所有患者在入院和出院时都填写了 CAT。我们对患者进行了为期 12 个月的随访，以收集再入院数据。用曲线下面积来衡量入院时的CAT、出院时的CAT和CAT变化对支气管扩张再入院的预测价值：46名患者在12个月内因支气管扩张加重而再次入院。入院时的高CAT是支气管扩张急性加重患者在12个月内再次入院的独立危险因素（危险比为3.201，95% CI为1.065-9.624；P结论：入院时的高CAT是支气管扩张急性加重患者在12个月内再次入院的有力预测因素：入院时的CAT是支气管扩张症加重患者再次入院的有力预测因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ERJ Open Research Medicine-Pulmonary and Respiratory Medicine

CiteScore

6.20

自引率

4.30%

发文量

273

审稿时长

8 weeks

期刊介绍： ERJ Open Research is a fully open access original research journal, published online by the European Respiratory Society. The journal aims to publish high-quality work in all fields of respiratory science and medicine, covering basic science, clinical translational science and clinical medicine. The journal was created to help fulfil the ERS objective to disseminate scientific and educational material to its members and to the medical community, but also to provide researchers with an affordable open access specialty journal in which to publish their work.